Clinical Trials on Impaired Fasting Glucose in Mexico
Total 707 results
-
TakedaCompletedDiabetes MellitusUnited States, Mexico
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2United States, Croatia, India, Israel, Italy, Japan, Mexico, Poland, Puerto Rico, Russian Federation, Slovakia, Spain, United Kingdom
-
SanofiCompletedDiabetes Mellitus, Type 2Algeria, Colombia, Egypt, Guatemala, India, Iran, Islamic Republic of, Lebanon, Mexico, Russian Federation, South Africa, Tunisia, Turkey, Ukraine, United Arab Emirates
-
TakedaCompletedDiabetes Mellitus, Type 2United States, Ukraine, Israel, Mexico, Romania, Russian Federation, South Africa, Czech Republic, Puerto Rico, Poland, Hungary, Lithuania, Slovakia
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesSweden, France, Italy, Mexico, South Africa, Spain, Germany, Netherlands, Argentina, United Kingdom
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States, Czechia, Puerto Rico, Poland, Mexico
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Australia, United States, France, Germany, Mexico, Puerto Rico, Peru
-
AstraZenecaCompleted
-
Ligand PharmaceuticalsCompletedType 2 Diabetes MellitusUnited States
-
Mannkind CorporationCompletedDiabetes Mellitus, Type 2United States, Brazil, Spain, Argentina, Canada, Chile, Mexico, Poland, Russian Federation, Ukraine, Czech Republic
-
Eli Lilly and CompanyCompletedType 1 Diabetes MellitusChina, Argentina, Mexico
-
AstraZenecaCompletedType 2 DiabetesUnited States, Mexico, Puerto Rico, Israel, Sweden, Italy, Philippines, Argentina
-
Daiichi Sankyo, Inc.CompletedType 2 DiabetesUnited States, Peru, Mexico
-
Janssen Research & Development, LLCCompletedDiabetes Mellitus, Type 2United States, Colombia, Mexico, Poland, Spain, India, Malaysia, Romania, South Africa, Sweden, Korea, Republic of, Estonia, Puerto Rico, Austria, Lithuania, Philippines, Guatemala, Iceland
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Puerto Rico, Poland, Canada, Austria, Mexico, Denmark, Croatia, Brazil, Argentina, Romania, South Africa, Russian Federation, France, Lithuania
-
Marinella TemprosaNational Institute on Aging (NIA)Enrolling by invitationDiabetes | Dementia | PreDiabetes | Alzheimer Disease | Dementia, VascularUnited States
-
NovartisCompletedType 2 Diabetes MellitusTaiwan, Philippines, Italy, Germany, Romania, Hungary, Australia, Korea, Republic of, Mexico
-
Eli Lilly and CompanyRecruitingDiabetes Mellitus, Type 2United States, Canada, Mexico, Argentina, Puerto Rico
-
PhenomixUnknownType 2 Diabetes MellitusUnited States, Argentina, Canada, India, Mexico
-
SanofiCompletedType 2 Diabetes MellitusBrazil, Peru, United States, Australia, Canada, Chile, Germany, Guatemala, Mexico, Poland, Romania, Russian Federation, Ukraine
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusKorea, Republic of, Mexico, Germany, Greece, Argentina, India, Australia
-
Hoffmann-La RocheCompletedDiabetesUnited States, Panama, Mexico, Canada, Estonia, Lithuania, Bulgaria, Romania, Latvia, Puerto Rico, United Kingdom
-
TakedaTakeda Development Center Americas, Inc.CompletedDiabetes Mellitus, Type 2United States, Italy, Mexico, Russian Federation, Brazil, Israel, Poland
-
TakedaCompletedDiabetes MellitusUnited States, Argentina, Mexico, Peru, Chile
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2Israel, Japan, Mexico, Argentina, Turkey, Australia, Algeria, Saudi Arabia, Brazil, China
-
PhenomixTerminatedType 2 Diabetes MellitusUnited States, Argentina, Canada, Mexico, India
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Argentina, Puerto Rico, Mexico
-
AstraZenecaBristol-Myers SquibbCompletedType 2 Diabetes MellitusUnited States, Canada, Mexico, India, Puerto Rico, Russian Federation, South Africa
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 1Russian Federation, United States, Australia, Greece, Argentina, Hungary, Brazil, Mexico, Romania
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Puerto Rico, Malaysia, Mexico, Turkey, Thailand, Korea, Republic of
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, United Kingdom, Mexico, Russian Federation, Japan, Canada, Italy, South Africa, Romania
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Canada, Thailand, Korea, Republic of, United Kingdom, China, Germany, Israel, Mexico, Argentina, Brazil, Colombia, Puerto Rico, Russian Federation
-
Mannkind CorporationCompletedDiabetes Mellitus | Upper Respiratory InfectionUnited States, Russian Federation, Canada
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedDiabetes Mellitus, Type II | Diabetes Mellitus, Non Insulin DependentUnited States, Poland, Bulgaria, India, Malaysia, Romania, Canada, Russian Federation, Argentina, Puerto Rico, Czech Republic, United Kingdom, Mexico
-
Valeritas, Inc.Integrated Medical DevelopmentCompletedType 2 Diabetes MellitusUnited States
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Canada, Korea, Republic of, Australia, New Zealand, Mexico, Brazil
-
Eli Lilly and CompanyCompletedType 2 DiabetesUnited States, France, India, Turkey, United Kingdom, Mexico, Brazil, Germany, Hungary, Puerto Rico, Saudi Arabia
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesUnited States, Canada, Mexico, Russian Federation
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Argentina, Canada, Peru, Australia, Latvia, Costa Rica, Russian Federation, New Zealand, Colombia, Mexico, Czech Republic, Ecuador
-
AstraZenecaCompletedSaxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and ExerciseDiabetes Mellitus, Type 2United States, Canada, Mexico, Puerto Rico, Taiwan, Australia
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesUnited States, Peru, Mexico, Colombia, Costa Rica
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Brazil, India, Puerto Rico, Romania, Poland, Germany, Croatia, Korea, Republic of, Mexico, United Kingdom, South Africa, Spain, Canada, Argentina, Czech Republic, Finland, France, Slovakia
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States, Mexico, India
-
Mannkind CorporationCompletedDiabetes, Type IUnited States, Spain, Brazil, Argentina, Canada, Chile, Mexico, Poland, Russian Federation, United Kingdom
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, India, Israel, Italy, Mexico, Poland, Russian Federation, Spain, Canada, Denmark, Taiwan, Malaysia, United Kingdom, Turkey, Germany, Bulgaria, Argentina, Australia, Thailand, Algeria, Brazil
-
TakedaCompletedDiabetes Mellitus, Type 2United States, Mexico, Guatemala
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesKorea, Republic of, United States, Mexico, Puerto Rico, Philippines, Russian Federation, Ukraine
-
AstraZenecaTerminatedDiabetes Mellitus, Type 2United States, Brazil, United Kingdom, Finland, Argentina, Canada, Mexico
-
AmgenCompletedType 2 Diabetes | Hypercholesterolemia | Mixed DyslipidemiaUnited States, Italy, Belgium, Spain, Canada, Poland, Mexico
-
AstraZenecaCompletedDiabetesUnited States, United Kingdom, Germany, Hungary, Mexico, Poland, Russian Federation, Romania, Czechia, Sweden